Ovid Therapeutics | 4:持股变动声明-董事 Bernstein Karen
Ovid Therapeutics | 4:持股变动声明-董事 Duncan Barbara Gayle
Ovid Therapeutics | 4:持股变动声明-董事 Friedman Bart
Ovid Therapeutics | 4:持股变动声明-董事 Fitzgerald Kevin Joseph
Ovid Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-EcoR1 Capital, LLC(0%),Oleg Nodelman(0%)等
Ovid Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BVF Partners L.P.(5.4%),BVF Inc.(5.4%)等
Ovid Therapeutics | 4:持股变动声明-高管 ALEXANDER MARGARET A.
Ovid Therapeutics | 3:首次持股声明-高管 ALEXANDER MARGARET A.
Ovid Therapeutics | 4:持股变动声明-高管 Rona Jeffrey A
Ovid Therapeutics | 4:持股变动声明-高管 LEVIN JEREMY M
Ovid Therapeutics | 4:持股变动声明-高管 Tardio Jason
Ovid Therapeutics | 4:持股变动声明-高管 Rona Jeffrey A
Ovid Therapeutics | 4:持股变动声明-董事 Poole Robert Michael
Ovid Therapeutics | 4:持股变动声明-高管 Perone Thomas Michael
Ovid Therapeutics | 4:持股变动声明-高管 LEVIN JEREMY M
Ovid Therapeutics | 4:持股变动声明-董事 Friedman Bart
Ovid Therapeutics | 4:持股变动声明-董事 Fitzgerald Kevin Joseph
Ovid Therapeutics | 4:持股变动声明-董事 Duncan Barbara Gayle
Ovid Therapeutics | 4:持股变动声明-董事 Bernstein Karen
Ovid Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Jeremy M. Levin(9.4%)